Bing

SEARCH HISTORY

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Arena Pharmaceuticals ( ARNA) as a weak on high ...
The Street · 7/1/2015
Arena Pharmaceuticals
There is some solace in that competitor Belviq from Arena (NASDAQ:ARNA) is trending negative ... relying on the anti-obesity space to drive the stock is a fools chase. Qsymia for sleep apnea? Studies under way, but …
Seeking Alpha · BySpencer Osborne · 3 hours ago
Qsymia Sales
Shares of Arena Pharmaceuticals (NASDAQ:ARNA) have been given a consensus rating of “Hold” by the seven brokerages that are currently covering the stock, Analyst Ratings Network.com reports. Two equities research analysts have rated the stock
sleekmoney.com · 6/26/2015
More from Bing News
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock has been on quite a roller coaster ride in 2015. A few weeks ago, ARNA shares roared 76% higher in a single day after positive early-stage trials for an autoimmune disease treatment gave investors a …
Investor Place · 1/22/2015
Investors in Arena Pharmaceuticals Inc (Symbol: ARNA) saw new options become available today, for the February 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA options chain for the new February …
NASDAQ · 1/8/2015
Investors in Arena Pharmaceuticals Inc (NASD: ARNA) saw new options become available today, for the September 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA options chain for the new September …
Forbes · 9/19/2013
Investors had high hopes for Arena's (NASDAQ: ARNA ) Belviq and VIVUS' (NASDAQ ... and fundamental valuations -- to see whether either stock is worth buying. Past sales growth Arena is partnered with Eisai (NASDAQOTH: ESALY ) in marketing Belviq …
The Motley Fool · 5/31/2014
As of late, it has definitely been a great time to be an investor in Arena Pharmaceuticals, Inc. (ARNA). The stock has moved higher by 24% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and ...
Yahoo Finance · 11/13/2014
Arena Pharmaceuticals, Inc. (ARNA) of the Healthcare sector is up 1.15% (change from open 0.46%) this morning trading at a volume of 147,361 shares and price of $4.38. Arena Pharmaceuticals, Inc. (ARNA)’s weekly performance is – 9.79% and …
wallstreetscope.com · 3/30/2015
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA): The stock price went almost to $5 last week, and that level was rejected once again, causing a strong pullback in the last trading session of the week. From a technical standpoint and based on the positive ...
Benzinga · 2/21/2015